Intramuscular Anti‐D treatment for immune thrombocytopenia: A single centre experience

Intravenous Anti‐Rhesus‐D immunoglobulin (Anti‐D) is a first‐line treatment option for immune thrombocytopenia in non‐splenectomised and RhD‐positive patients. In this report, we retrospectively review our experience with intramuscular (IM) Anti‐D treatment in 74 adult patients between 1990 and 2018...

Descripción completa

Detalles Bibliográficos
Autores principales: Lakhwani, Sunil, López‐Las Heras, Alberto, Rodríguez‐García, Pablo, Iraheta, Sandra, Martín‐Santos, Taida, Rodríguez‐Salazar, María José, Machado, Patricia, Hernández, Miguel‐Teodoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Platelets, Thrombosis and Haemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091692/
https://www.ncbi.nlm.nih.gov/pubmed/36198407
http://dx.doi.org/10.1111/bjh.18484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091692/
https://www.ncbi.nlm.nih.gov/pubmed/36198407
http://dx.doi.org/10.1111/bjh.18484

Ejemplares similares